BioCentury
ARTICLE | Company News

Biovitrum hematology, endocrine, neurology news

January 26, 2009 8:00 AM UTC

Biovitrum markets products for hemophilia, chemotherapy-induced nausea and vomiting (CINV), chemotherapy-induced oral mucositis and rheumatoid arthritis (RA). Last year, the company discontinued its e...